Warren Eric's most recent trade in Esperion Therapeutics Inc. was a trade of 108 Common Stock done at an average price of $1.0 . Disclosure was reported to the exchange on April 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Esperion Therapeutics Inc. | Eric Warren | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 0.98 per share. | 17 Apr 2025 | 108 | 370,218 (1%) | 0% | 1.0 | 106 | Common Stock |
| Esperion Therapeutics Inc. | Eric Warren | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 1.49 per share. | 18 Mar 2025 | 2,433 | 370,326 (1%) | 0% | 1.5 | 3,618 | Common Stock |
| Esperion Therapeutics Inc. | Eric Warren | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2025 | 213,000 | 372,759 (1%) | 0% | 0 | Common Stock | |
| Esperion Therapeutics Inc. | Eric Warren | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2025 | 191,000 | 191,000 | - | - | Stock Option (right to buy) | |
| Esperion Therapeutics Inc. | Eric Warren | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 1.87 per share. | 19 Feb 2025 | 239 | 159,759 (0%) | 0% | 1.9 | 446 | Common Stock |
| Esperion Therapeutics Inc. | Eric Warren | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 2.26 per share. | 17 Jan 2025 | 123 | 159,998 (0%) | 0% | 2.3 | 278 | Common Stock |
| Esperion Therapeutics Inc. | Warren Eric | Chief Commercial Officer | 17 Dec 2024 | 2,234 | 160,121 (0%) | 0% | 2.4 | 5,426 | Common Stock | |
| Esperion Therapeutics Inc. | Eric Warren | Chief Commercial Officer | 19 Nov 2024 | 197 | 162,355 (0%) | 0% | 2.2 | 427 | Common Stock | |
| Esperion Therapeutics Inc. | Eric Warren | Chief Commercial Officer | 17 Oct 2024 | 107 | 162,552 (0%) | 0% | 2.1 | 227 | Common Stock | |
| Esperion Therapeutics Inc. | Eric Warren | Chief Commercial Officer | 17 Sep 2024 | 2,608 | 162,659 (0%) | 0% | 1.8 | 4,650 | Common Stock | |
| Esperion Therapeutics Inc. | Eric Warren | Chief Commercial Officer | 19 Aug 2024 | 211 | 165,267 (0%) | 0% | 1.9 | 411 | Common Stock | |
| Esperion Therapeutics Inc. | Eric Warren | Chief Commercial Officer | 17 Jul 2024 | 108 | 165,478 (0%) | 0% | 2.6 | 279 | Common Stock | |
| Esperion Therapeutics Inc. | Eric Warren | Chief Commercial Officer | 18 Jun 2024 | 2,540 | 165,586 (0%) | 0% | 2.9 | 7,254 | Common Stock | |
| Esperion Therapeutics Inc. | Eric Warren | Chief Commercial Officer | 17 May 2024 | 192 | 168,126 (0%) | 0% | 2.5 | 477 | Common Stock | |
| Esperion Therapeutics Inc. | Eric Warren | Chief Commercial Officer | 14 Mar 2024 | 150,000 | 150,000 | - | - | Stock Option (right to buy) | ||
| Esperion Therapeutics Inc. | Eric Warren | Chief Commercial Officer | 14 Mar 2024 | 100,000 | 168,318 (0%) | 0% | 0 | Common Stock | ||
| Esperion Therapeutics Inc. | Eric Warren | Chief Commercial Officer | 18 Aug 2023 | 243 | 69,060 (0%) | 0% | 1.4 | 344 | Common Stock | |
| Esperion Therapeutics Inc. | Eric Warren | Chief Commercial Officer | 19 Jul 2023 | 106 | 69,303 (0%) | 0% | 1.6 | 168 | Common Stock | |
| Esperion Therapeutics Inc. | Eric Warren | Chief Commercial Officer | 21 Jun 2023 | 603 | 69,409 (0%) | 0% | 1.5 | 894 | Common Stock | |
| Esperion Therapeutics Inc. | Eric Warren | Chief Commercial Officer | 17 May 2023 | 219 | 70,012 (0%) | 0% | 1.6 | 356 | Common Stock | |
| Esperion Therapeutics Inc. | Eric Warren | Chief Commercial Officer | 19 Apr 2023 | 115 | 70,231 (0%) | 0% | 1.3 | 147 | Common Stock | |
| Esperion Therapeutics Inc. | Eric Warren | Chief Commercial Officer | 17 Mar 2023 | 526 | 70,346 (0%) | 0% | 1.8 | 937 | Common Stock | |
| Esperion Therapeutics Inc. | Eric Warren | Chief Commercial Officer | 14 Mar 2023 | 94,500 | 94,500 | - | - | Stock Option (right to buy) | ||
| Esperion Therapeutics Inc. | Eric Warren | Chief Commercial Officer | 14 Mar 2023 | 22,300 | 70,872 (0%) | 0% | 0 | Common Stock | ||
| Esperion Therapeutics Inc. | Eric Warren | Chief Commercial Officer | 07 Mar 2023 | 5,090 | 48,572 (0%) | 0% | 5.1 | 25,730 | Common Stock | |
| Esperion Therapeutics Inc. | Eric Warren | Chief Commercial Officer | 18 Oct 2022 | 107 | 53,662 (0%) | 0% | 7.7 | 823 | Common Stock | |
| Esperion Therapeutics Inc. | Eric Warren | Chief Commercial Officer | 19 Sep 2022 | 255 | 53,769 (0%) | 0% | 6.9 | 1,765 | Common Stock | |
| Esperion Therapeutics Inc. | Eric Warren | Chief Commercial Officer | 31 Aug 2022 | 1,000 | 54,024 (0%) | 0% | 7.5 | 7,460 | Common Stock | |
| Esperion Therapeutics Inc. | Eric Warren | Chief Commercial Officer | 17 Aug 2022 | 199 | 53,024 (0%) | 0% | 6.8 | 1,356 | Common Stock | |
| Esperion Therapeutics Inc. | Eric Warren | Chief Commercial Officer | 19 Jul 2022 | 431 | 53,223 (0%) | 0% | 6.6 | 2,837 | Common Stock | |
| Esperion Therapeutics Inc. | Eric Warren | Chief Commercial Officer | 17 Jun 2022 | 256 | 53,654 (0%) | 0% | 4.9 | 1,254 | Common Stock | |
| Esperion Therapeutics Inc. | Eric Warren | Chief Commercial Officer | 07 Jun 2022 | 52,000 | 52,000 | - | - | Stock Option (right to buy) | ||
| Esperion Therapeutics Inc. | Eric Warren | Chief Commercial Officer | 17 May 2022 | 196 | 53,910 (0%) | 0% | 6.0 | 1,172 | Common Stock | |
| Esperion Therapeutics Inc. | Eric Warren | Chief Commercial Officer | 14 Mar 2022 | 13,000 | 54,106 (0%) | 0% | 0 | Common Stock |